Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In silico approach of modified melanoma peptides and their immunotherapeutic potential.

Physical chemistry chemical physics : PCCP - 4 Feb 2021

Pereira A C L, Bezerra K S, Santos J L S, I N Oliveira J, Freire V N, Fulco U L

Abstract excerpt

Melanoma is a type of skin cancer with increasing incidence worldwide and high lethality. Conventional forms of treatment are not effective in advanced cancer stages. Hence, immunotherapeutic approaches have been tested to modulate immune response against tumor cells. Some vaccine models using tumor-associated antigens (TAAs) such as glycoprotein 100 (gp100) have been studied, but their expected effectiveness has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computer Simulation
Share to gp100 Melanoma Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-A2 Antigen

Share to Models, Chemical

Share to Mutation

Share to Peptide Fragments

Share to Protein Binding

Share to Thermodynamics

Source

Identifiers

PMID: 33470998
DOI: 10.1039/d0cp05322h

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In silico approach of modified melanoma peptides and their immunotherapeutic potential.PMID 33470998Read ↗

Carrier-Free Nanovaccine: An Innovative Strategy for Ultrahigh Melanoma Neoantigen LoadingSemantic proximity Read ↗

Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicitySemantic proximity Read ↗

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.Semantic proximity Read ↗

Immunoinformatic design of multi epitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a targetSemantic proximity Read ↗

VaccImm: simulating peptide vaccination in cancer therapy.Semantic proximity Read ↗

Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approachSemantic proximity Read ↗

Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccineSemantic proximity Read ↗

CD171 Multi-epitope peptide design based on immuno-informatics approach as a cancer vaccine candidate for glioblastomaSemantic proximity Read ↗

Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.Semantic proximity Read ↗

Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation AnalysisSemantic proximity Read ↗

Design of a novel multiepitope vaccine against glioblastoma by in silico approachesSemantic proximity Read ↗

Computational Immunogenetic Analysis of Botulinum Toxin A Immunogenicity and HLA Gene Haplotypes: New InsightsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.